Cargando…
Molecular Signatures of Response to Mecasermin in Children With Rett Syndrome
Rett syndrome (RTT) is a devastating neurodevelopmental disorder without effective treatments. Attempts at developing targetted therapies have been relatively unsuccessful, at least in part, because the genotypical and phenotypical variability of the disorder. Therefore, identification of biomarkers...
Autores principales: | Shovlin, Stephen, Delepine, Chloe, Swanson, Lindsay, Bach, Snow, Sahin, Mustafa, Sur, Mriganka, Kaufmann, Walter E., Tropea, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197456/ https://www.ncbi.nlm.nih.gov/pubmed/35712450 http://dx.doi.org/10.3389/fnins.2022.868008 |
Ejemplares similares
-
Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions
por: Bach, Snow, et al.
Publicado: (2021) -
Placebo‐controlled crossover assessment of mecasermin for the treatment of Rett syndrome
por: O'Leary, Heather M., et al.
Publicado: (2018) -
Transcriptome level analysis in Rett syndrome using human samples from different tissues
por: Shovlin, Stephen, et al.
Publicado: (2018) -
Illness Severity, Social and Cognitive Ability, and EEG Analysis of Ten Patients with Rett Syndrome Treated with Mecasermin (Recombinant Human IGF-1)
por: Pini, Giorgio, et al.
Publicado: (2016) -
Label-free three-photon imaging of intact human cerebral organoids for tracking early events in brain development and deficits in Rett syndrome
por: Yildirim, Murat, et al.
Publicado: (2022)